Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial-Reference-Cited by-同舟云学术

Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial

Published:2017-01-10 Issue:1 Volume:17 Page:
ISSN:1471-2377
Container-title:BMC Neurology
language:en
Short-container-title:BMC Neurol

Author:

Feil Katharina^ORCID,Adrion Christine,Teufel Julian,Bösch Sylvia,Claassen Jens,Giordano Ilaria,Hengel Holger,Jacobi Heike,Klockgether Thomas,Klopstock Thomas,Nachbauer Wolfgang,Schöls Ludger,Stendel Claudia,Uslar Ellen,van de Warrenburg Bart,Berger Ingrid,Naumann Ivonne,Bayer Otmar,Müller Hans-Helge,Mansmann Ulrich,Strupp Michael

Funder

Bundesministerium für Bildung und Forschung

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12883-016-0786-x.pdf

Reference33 articles.

1. Jacobi H, et al. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology. 2011;77(11):1035–41.

2. Klockgether T. Sporadic adult-onset ataxia of unknown etiology. Handb Clin Neurol. 2012;103:253–62.

3. Perlman SL. Symptomatic and disease-modifying therapy for the progressive ataxias. Neurologist. 2004;10(5):275–89.